ARCHIVES

Text of PDQ Statement on Breast Screening

This article is from The Cancer Letter archive.

Vol. 19 No. 36 | September 17, 1993

Download PDF Visit The Full Archive

Related Articles

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994

Secret Budget Sessions Ended; HEW Out To Lim. Future NCI Funds

April 2, 1976